Translational Research Program
Mission Statement
____________________________________________________________________
The mission of the Translational Research Program (TRP) at Children's Hospital Boston is to stimulate the development of non-clinical and human clinical trials that seek to improve the care of children, and to ensure adequate infrastructure to support non-clinical and clinical translational research projects.
Elements of the program
- Stimulative grants-in-aid awarded for projects containing novel ideas or applications.
- Improvement in institutional cores needed to support disease-specific non-clinical and early phase human studies.
- Multidisciplinary retreats to foster interactions across the spectrum of research and clinical activities.
- Funding for the development of faculty and staff in translational research activities at Children's.
Pilot & Core Grants 2012
The TRP is pleased to announce our fifth year of funding will take place in 2012! We will be accepting applications for Pilot and Core Grants.
Letter of Intent due February 3, 2012.
Full Application due April 9, 2012.
Please submit all materials to trp@childrens.harvard.edu. Click here to learn more about the Pilot Grants, to download the full application, and to see a list of past recipients. Click here to learn more about the Core Grants, to download the full application, and to see a list of past recipients.
David Williams discusses taking Pediatric Research from Bench to Bedside
David Williams, MD, discusses the importance of bridging the translational gap, the challenges in doing so, and how Children's plans to accelerate this process in the future. He also speaks to the need for more research funding for pediatrics.
Click here to view the video.
FDA Symposium Lecture Materials
The TRP would like to thank everyone who attended the FDA Symposium, "Moving Ideas from Bench to Bedside: Challenges of Pre-Clinical Development" on September 30th. Below are the links to Dr. Melissa Tassinari's lecture about the criteria the FDA requires in a pre-clinical program for new drug development as well as Dr. Charles Berde's experience developing two new anesthetic drugs and the challenges he is facing.




